Rabbit polyclonal antibodies directed against purified Streptococcus mutans L-(+)-lactate dehydrogenase reacted with the purified enzyme, giving a marked deviation of its kinetic parameters. The enzyme affinity for pyruvate or NADH decreased in the presence of antibody, the affinity for fructose 1,6-diphosphate (FDP) appeared to be slightly affected, and the cooperativity of the 
effect was observed when the enzyme was preincubated with FDP prior to the antibody adjunction. An enzyme-linked immunosorbent assay allowed detection of a 30% decrease in enzyme-antibody fixation when FIDP was added. The protective effect observed with FDP could be correlated with a conformational change induced by the activator. A decrease of antibody binding in the presence of FDP was also obtained with S. sanguis, Actinomyces viscosus, and LactobaciUus casei lactate dehydrogenases, which reflects a similar mechanism of activation among lactic bacteria. NADH did not offer any protection against antibody inhibition or fixation, and the coenzyme affinity decrease could be attributed to an indirect mechanism. On the contrary, pyruvate and the immunoglobulins apparently could compete for specific binding sites. A decrease of antibody binding was also obtained with three heterologous lactic bacterial lactate dehydrogenases, indicating a conservation of antigenic determinants implicated in the substrate binding.
Lactic bacterial L-(+)-lactate dehydrogenase (LDH; EC 1.1.1.27), a key enzyme in fermentation metabolism, exhibits structural and kinetic parameters which are closely related (10) . Enzymes are generally activated by fructose 1,6-diphosphate (FDP). They consist of four identical subunits, with two or more binding sites for each ligand. A significant degree of similarity exists between their active centers, at least for the Lactobacillus casei (14) and the Streptococcus cremoris (7) enzymes, when respectively compared with vertebrate enzymes. Immunological crossreactions between extragenera lactic bacterial LDHs revealed antigenic relationships (21) , confirming the structural conservation of these molecules.
The LDH from S. mutans OMZ 175, a cariogenic strain (11), was recently purified to homogeneity (21 (20, 21) . Bacteria were prepared from exponentialphase cultures grown in brain heart infusion broth (Difco Laboratories, Detroit, Mich.).
The S. mutans LDH cytoplasmic fractions were purified to homogeneity by DEAE-Sephacel and Blue-Sepharose CL-6B chromatographies and S200 Sephacryl gel permeation (21 (21) . Preimmune sera were obtained before rabbit immunization, and the IgG fractions were obtained as described above.
Antibody specificity was checked by crossed-immunoelectrophoresis (24) and Western blotting procedures (23) after sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Enzyme assay and inhibition experiments. LDH activity and the kinetic parameters were determined as previously described (21) . Kinetic (12) . On the other hand, the antibodies reacted only with a single protein in crude cytoplasmic extracts from the different bacteria after sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transfer to nitrocellulose paper (21) .
Effect of antibody on kinetic parameters of S. mutans LDH.
Modifications of the enzyme kinetic constants were determined after incubation of the purified LDH (2.6 ,ug) with anti-LDH antibodies. The amounts of IgG during the preincubation stage were 125 and 225 jig, which allowed inhibi- Effect of ligands on antibody-mediated inhibition. The S. mutans LDH was preincubated with FDP, pyruvate, or NADH for 1 h at 4°C before adjunction of specific or preimmune antibodies, and the mixtures were then incubated for 20 h at 4°C. Table 2 shows the residual activity of assays containing 2.6 ,ug of LDH and various amounts of ligands. In controls without any ligand, 80% inhibition of the original enzymatic activity was observed when 700 ,ug of anti-S. mutans IgG was added. Addition of FDP allowed a 25% decrease in inhibition, resulting in 54% activity inhibition with 1.65 mM FDP. Pyruvate had no detectable effect on enzyme inactivation, while NADH slightly enhanced the inhibition.
Effect of ligands on antibody binding. An enzyme-linked immunosorbent assay procedure was used to assess the effect of ligands on the antigen-antibody recognition. The S. mutans LDH was coated in wells of a polyvinyl microtitration plate, and the amount of fixed antibody was monitored as described in Materials and Methods. A possible decrease of the antigen-antibody recognition was analyzed by addition of increasing concentrations of each ligand to the antibody mixture. A maximal inhibition of 30%o of antibody binding was observed with concentrations of FDP higher than 0.5 mM (Fig. 2A ). An inhibition of 15% was also obtained with concentrations of pyruvate higher than 30 mM (Fig. 2B) . The coenzyme exhibited no interfering effect (data not shown).
The (11.5 ,ug/ml; *), S. sanguis LDH (200 ,ug/ml; 0), A. viscosus LDH (500 ,ug/ml; A), and L. casei (500 ,ug/ml; *). Anti-S. mutans LDH IgG fractions (12.5 ,ug/ml) were incubated for 2 h at 37°C with the enzymes in the presence or absence of various concentrations of FDP (A) or pyruvate (B). The enzyme conjugate goat anti-rabbit antibody (diluted 1:500) was incubated for 1 h at 30°C. Hydrolysis time was (Fig. 2A) . On the other hand, an 8% reduction in antibody binding appeared when pyruvate was added during the recognition of the S. sanguis LDH by antibody. An 18% decrease in antibody binding was observed with the A. viscosus extract and one of 25% was seen with the L. casei enzyme (Fig. 2B) . NADH did not offer any hindrance to antibody accessibility, as for the S. mutans LDH.
DISCUSSION
In a previous work, we showed that antibodies obtained against S. mutans OMZ 175 LDH recognized the native enzyme and led to almost complete inhibition of enzymatic activity (21) . The binding of FDP partially reduces this inhibition by lowering the antibody accessibility (Table 2 , Fig. 2A ). However, antibodies do not inhibit the effector binding since no increase in the Mo.sv value for FDP is observed in the presence of antibody (Table 1) . Therefore, the partial protection against the immunological neutralization of the enzyme must be caused by an indirect mechanism. It seems reasonable to assume that FDP induces conformational changes in the quaternary structure of the enzyme, as often described for regulatory molecules (6) . This conformational change could be correlated with the enzyme activation process induced by FDP, since the concentrations of activator that allow the maximal activation (21) and the maximal protection of the enzymatic activity against antibody are in the same order. The possibility of a conformational change is confirmed by the drastic decrease of the effector binding cooperativity when antibodies are fixed. Thus, the FDP-induced conformational changes render some determinants unavailable for combination with antibodies, while the fixation of these latter molecules hinders the flexibility of the enzyme. The demonstration of common determinants implicated by the effector binding among heterologous LDHs allows a generalization of the concept of an activation process by conformational changes for the FDP-dependent LDHs tested. These observations broaden the previous findings on the L. casei, L. curvatus (18) , and S. faecalis (25) LDHs in which the activation (18) or the thermal protection (25) induced by FDP is correlated with conformational changes of the three enzymes.
On the other hand, NADH does not offer any protection against antibody inhibition or fixation, as was the case for vertebrate LDHs which are not protected by their substrates (6) . A direct competition between antibody and coenzyme binding does not occur, although competitions between the binding of antibody and NADH (or NADPH) in favor of the coenzyme are often described for dehydrogenases (16) . However, a decrease in the enzyme's affinity for its coenzyme has been observed. This cannot be attributed to an indirect effect, resulting from inhibition of either FDP or pyruvate binding, since NADH binds independently (21) , probably according to a compulsory binding order in which NADH is bound first, as for other bacterial (7, 12) or vertebrate (15) LDHs. Thus, it might be expected that the binding hindrance of NADH results from a "blockade" by steric hindrance or conformational change (6) . As antibodies seem to block both the structural modification induced by FDP and the accessibility of the coenzyme by steric hindrance, it could be interesting to correlate the two mechanisms, as for the L. casei LDH, where spectroscopic measurements showed that the bound coenzyme was affected by the effector binding (18) .
In spite of the lack of protection against immunological neutralization, pyruvate inhibits antibody fixation. The decrease of affinity for pyruvate observed in the presence of antibody does not result from an alteration of the FDP binding, since antibodies (i) do not reduce the enzyme affinity for the activator and (ii) lower the substrate binding cooperativity, while a decrease in the optimal effector concentration leads to a drastic lowering of the affinity of the enzyme for pyruvate and to an increase in the cooperativity of substrate binding (4, 8, 12, 21) . This decrease results probably from a direct competition between the binding of pyruvate and antibody. The absence of any protective effect of pyruvate against the antibody inhibition might be attributed to the existence of two binding sites for the substrate, a noncatalytic binding site and a catalytic binding site, as described for S. mutans NCTC 10449 (4) and L. casei (12) LDHs. The antibody binding inhibition in the presence of pyruvate was also reported for the FDP-dependent S. sanguis, L. casei, and A. viscosus LDHs. The inhibition level of antibody fixation appeared higher when the number of common epitopes decreased: a 25% antibody binding inhibition was observed in the presence of pyruvate with the L. casei enzyme, which is the less immunologically related enzyme (21) . This inhibition decreases with the A. viscosus LDH and appears very weak with the closely related S. sanguis LDH, as for the S. mutans enzyme. This appears strongly suggestive of a direct competition of antibodies for specific pyruvate binding sites which seem to be preserved by evolution. In this regard, it could be interesting to correlate this common antigenic determinant with the noncatalytic pyruvate binding site detected on the L. casei LDH (5) . This latter region presented a sequential homology with the anion binding site of vertebrate LDHs (9, 14) onto which pyruvate binds (1), indicating a high degree of conservation. However, the use of polyclonal antibodies did not allow a direct demonstration of identity between the pyruvate binding site of bacterial LDHs and the vertebrate anion binding site, since no immunological cross-reaction could be observed between bacterial and vertebrate LDHs (21) . The use of monoclonal antibody directed against the pyruvate binding domain might provide additional assertions on the regulation and evolution of bacterial LDHs.
